United States

Back to map

Showing 271-280 of 352 grants

Title Institution Researcher Program Duration Total Award Amount
Treatment of type-1 diabetes with apolipoprotein A4 – efficacy and mechanisms University of Cincinnati Min Liu Cures 01-March-2023 to 28-February-2027 $721.291,00
Charting a Path for Continuous Insulin Monitoring University of Cincinnati Ryan White Improving Lives 01-April-2024 to 31-March-2027 $708.147,00
Understanding Early Histopathological Changes in the Pancreas of those at Risk for Type 1 Diabetes Development University of Florida Alexandra Rippa Cures 01-March-2026 to 28-February-2029 $237.690,00
Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort University of Florida Angelica Ahrens Cures 01-April-2026 to 31-March-2027 $199.235,28
NIICHE: A Human 3‑D Pancreatic Hydrogel Platform for Real‑Time Investigation of β‑Cell Immunogenicity and Therapeutic Screening in Type 1 Diabetes University of Florida Cherie Stabler Cures 01-October-2026 to 30-September-2027 $300.000,00
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D University of Florida Graciela Lorca Cures 01-September-2019 to 31-August-2026 $355.941,78
Network for Pancreatic Organ Donors – nPOD University of Florida Mark Atkinson Cures 01-October-2023 to 31-December-2026 $8.100.000,00
PRISE-hATG: Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset T1D Treated with Human Anti-Thymocyte Globulin University of Florida Michael Haller Cures 01-July-2026 to 30-June-2030 $5.331.741,16
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2 University of Florida Todd Brusko Cures 01-September-2024 to 31-October-2026 $500.000,00
NKG2D Signaling as a Critical Modulator of Autoreactive CD8⁺ T Cell Differentiation and β Cell Destruction in Type 1 Diabetes University of Kansas Medical Center Research Institute, Inc. Ambika Dudhate Cures 01-March-2026 to 28-February-2029 $274.010,00